Scanner with improved functionality installed
A life science consultant from TTP plc has delivered the next version of the Lumito’s scanner, with improved functionality, and assisted in the installation process. The new scanner entails, among other things, greater capacity to test new indications and to complete the evaluation of the breast cancer marker Her2. – Due to the pandemic, this was […]
Patent application approved in an additional country – Brazil
Lumito's (https://lumito.se/en/home/) basic patent, a patent in the first patent family protecting the use of upconverting nanoparticles (UCNPs) for imaging in scattering materials, such as human tissue, has now been approved in Brazil. Among other countries, the company is awaiting response to an application concerning India. – The approval of our basic patent is an important […]
Lumito develops the tissue diagnostics of the future – basic patent now granted in Europe
Lumito's product comprises an instrument and staining reagents based on UCNPs (up-converting nanoparticles). The instrument is intended for use in tissue diagnostics, to provide pathologists visual depictions of tissue samples as an input for making diagnosis. The technology is patented across three global patent families that cover the creation of high-quality imaging of tissue, for […]
Patent approved also in India
The patent describing the use of light pulses to improve the efficiency of the technique and shorten imaging times has now also been granted in India. The patent has already been approved in Europe, South Korea, Australia, China, South Africa, USA and Japan and we are awaiting approval in Canada. – The grant of the […]
Processes in place for ISO 13485 qualification
Confirmation from an independent auditing company now shows that Lumito has the processes in place to qualify for ISO 13485. The first step has been passed and the next step in the process is for the company to demonstrate that the processes are being followed in practice. The processes reflect that the company is well […]
With potential to revolutionize tissue immunostaining
Picture of UCNP-stained HER2 marker in breast tissue. The colour is easily digitally edited after the image capture, which makes it possible to highlight interesting areas in each sample. The colours of the markers are digitally edited after the image capture. Lumito’s advisors in the field of pathology have now had the opportunity to review […]
Lumito initiates process to engage in dialogue with future partners
The awareness about Lumito's (https://lumito.se/en/home/) potential is on the rise among companies active in digital pathology, and Lumito has received approaches from leading companies in health technologies and diagnostics. The interest in the Company demonstrates that Lumito is in just the right phase. Diagnostics is currently a bottleneck of the system. More and more laboratories abandon […]
Two European patents approved for tissue diagnostics
"Another milestone is passed as Lumito's third patent family now is granted in Europe as the first region. The patent (WO2018224688A1), ”A method of anaIysing a sampIe for at Ieast one anaIyte”, specifically contains the area of application that Lumito's first product launch is targetingand protects the Company's in vitro diagnostics based on upconversion nanoparticles (UCNP). We hope that […]
Stefan Nilsson, CEO of Lumito, has passed away
"It is with great sadness that we announce this tragic and highly unexpected message," says Masoud Khayyami, Chairman of the Board of Lumito. “Stefan Nilsson has left us very unexpectedly. He passed away yesterday due to a heart attack, in connection with exercise on Friday. Our thoughts go to Stefan's family and loved ones.” “With […]
The need for better diagnostic reliability is great and immediate, and Lumito has a solution with potential
These are the words of Björn Isfoss, Chief Pathologist and advisor to Lumito. The cooperation is fully in line with Lumito's strategy to build its own organization with the skills and capacity to manage and develop the current and future products. – I have chosen to work together with Lumito, whose technology has the capacity to meet […]
